News for Cogint Stock (COGT)

Cogent Biosciences to Present at Ladenburg Thalmann Virtual Healthcare Conference 2021

PRNewsWire • 06/29/21

Cogent Biosciences to Present at Jefferies Virtual Healthcare Conference 2021

PRNewsWire • 05/26/21

Cogent Biosciences Provides Corporate Updates and Reports First Quarter 2021 Financial Results

PRNewsWire • 05/12/21

Cogent Biosciences Appoints Evan Kearns as Chief Legal Officer

PRNewsWire • 05/03/21

Cogent Biosciences Announces Creation of Cogent Research Team

PRNewsWire • 04/06/21

Cogent Biosciences, Inc. (COGT) Reports Q4 Loss, Lags Revenue Estimates

Zacks Investment Research • 03/16/21

Cogent Biosciences Reports Fourth Quarter 2020 and Full Year 2020 Financial Results

PRNewsWire • 03/16/21

Cogent Biosciences Appoints Accomplished Finance Executive Todd E. Shegog to its Board of Directors

PRNewsWire • 02/22/21

Cogent Biosciences to Present at Virtual 10th Annual SVB Leerlink Global Healthcare Conference 2021

PRNewsWire • 02/18/21

Cogent Biosciences to Present at LifeSci Partners Virtual Precision Oncology Day 2021

PRNewsWire • 02/11/21

Cogent Biosciences Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of Underwriter's Option to Purchase Additional Shares

PRNewsWire • 12/04/20

Cogent Biosciences Announces $60.0 Million Public Offering of Shares of Common Stock

PRNewsWire • 11/30/20

Cogent Biosciences to Participate in 3rd Annual Evercore ISI HealthCONx Virtual Conference

PRNewsWire • 11/20/20

Cogent Biosciences to Present at Jefferies 2020 Virtual London Healthcare Conference

PRNewsWire • 11/12/20

Cogent Biosciences Appoints Andrew Robbins as Chief Executive Officer

PRNewsWire • 10/26/20